thisdrug what a medicine's name tells you

WHO naming stem · suffix · 15 listed names

-gliflozin

sodium glucose co-transporter inhibitors, phlorizin derivatives

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -gliflozin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -gliflozin. So the letters gliflozin sit at the end of the name (…gliflozin).

All 15 names WHO lists under -gliflozin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. atigliflozin
  2. bexagliflozin
  3. canagliflozin
  4. dapagliflozin
  5. empagliflozin
  6. ertugliflozin
  7. ipragliflozin
  8. licogliflozin
  9. luseogliflozin
  10. mizagliflozin
  11. remogliflozin etabonate
  12. sergliflozin etabonate
  13. sotagliflozin
  14. tofogliflozin
  15. velagliflozin

Decode another name

Decoded

atigliflozin

Listed INNCarries 2 WHO stems, most specific first: -gliflozin …

  • -gliflozinend of the nameWHO lists it hereWHO definition: sodium glucose co-transporter inhibitors, phlorizin derivatives
  • gliinside the nameWHO lists it hereWHO definition: antihyperglycaemics

“atigliflozin” is an INN that WHO lists under -gliflozin, gli in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -gliflozin (Part II B) and the 15 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.